Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;36(2):111-117.
doi: 10.6515/ACS.202003_36(2).20190731A.

Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris

Affiliations

Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris

Ayhan Küp et al. Acta Cardiol Sin. 2020 Mar.

Abstract

Background: Endothelial cell-specific molecule 1 (ESM-1 or endocan) is an immunoinflammatory marker strongly associated with inflammation, vascular endothelial dysfunction and atherosclerosis. We explored the relationship between serum endocan concentrations and coronary in-stent restenosis (ISR).

Methods: Fifty consecutive patients with ISR and 50 control subjects were included in this study. Clinical data and angiographic characteristics were collected. Serum endocan concentrations were measured using an enzyme-linked immunosorbent assay.

Results: All included patients were divided into four quartiles based on their concentrations of endocan: quartile 1 (0.62-1.31 ng/mL), quartile 2 (1.33-1.74 ng/mL), quartile 3 (1.75-2.77 ng/mL) and quartile 4 (2.78-4.24 ng/mL). The rates of ISR were 16%, 24%, 68%, and 92%, respectively. The patients in quartile 4 had significantly higher rates of ISR than the other groups (p < 0.001). Logistic regression analysis indicated that endocan concentration [odds ratio = 8.65, 95% confidence interval 3.56-20.94; p < 0.001] was an independent predictor of ISR. Receiver operating characteristic curve analysis was used to explore the relationship between endocan and ISR. Using a cutoff value of 1.625 ng/mL, endocan predicted ISR with a sensitivity of 86% and a specificity of 78%.

Conclusions: Our findings suggest that plasma endocan levels may be a novel biomarker of endothelial dysfunction in patients with ISR.

Keywords: Biomarker; Endocan; Endothelial cell-specific molecule 1; Inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ISR rate stratified by endocan quartiles. ISR, in-stent restenosis.
Figure 2
Figure 2
The receiver-operating characteristics (ROC) curve analysis of endocan for predicting in-stent restenosis.

Similar articles

Cited by

References

    1. Patel MJ, Patel SS, Patel NS, Patel NM. Current status and future prospects of drug eluting stents for restenosis. Acta Pharma. 2012;62:473–476. - PubMed
    1. Paudel B, Xuan GJ, Chun ZF. Analysis of clinical factors affecting the restenosis following percutaneous coronary intervention. Nepal Med Coll J. 2005;7:101–106. - PubMed
    1. Guildford AL, Stewart HJ, Morris C, Santin M. Substrate-induced phenotypic switches of human smooth cells: an in vitro study of in-stent restenosis activation pathways. J R Soc Interface. 2011;8:641–649. - PMC - PubMed
    1. Lin JS, Wang CJ, Li WT. Inhibitory effect of photodynamic therapy with indocyanine green on rat smooth muscle cells. Acta Cardiol Sin. 2019;35:65–74. - PMC - PubMed
    1. Seob Lim K, Park JK, Ho Jeong M, et al. Anti-inflammatory effect of gallic acid-eluting stent in a porcine coronary restenosis model. Acta Cardiol Sin. 2018;34:224–232. - PMC - PubMed

LinkOut - more resources